These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 9634050)

  • 1. Decreased incidence of prostate cancer with selenium supplementation: results of a double-blind cancer prevention trial.
    Clark LC; Dalkin B; Krongrad A; Combs GF; Turnbull BW; Slate EH; Witherington R; Herlong JH; Janosko E; Carpenter D; Borosso C; Falk S; Rounder J
    Br J Urol; 1998 May; 81(5):730-4. PubMed ID: 9634050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group.
    Clark LC; Combs GF; Turnbull BW; Slate EH; Chalker DK; Chow J; Davis LS; Glover RA; Graham GF; Gross EG; Krongrad A; Lesher JL; Park HK; Sanders BB; Smith CL; Taylor JR
    JAMA; 1996 Dec; 276(24):1957-63. PubMed ID: 8971064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selenium supplementation and secondary prevention of nonmelanoma skin cancer in a randomized trial.
    Duffield-Lillico AJ; Slate EH; Reid ME; Turnbull BW; Wilkins PA; Combs GF; Park HK; Gross EG; Graham GF; Stratton MS; Marshall JR; Clark LC;
    J Natl Cancer Inst; 2003 Oct; 95(19):1477-81. PubMed ID: 14519754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of cancer risk with an oral supplement of selenium.
    Combs GF; Clark LC; Turnbull BW
    Biomed Environ Sci; 1997 Sep; 10(2-3):227-34. PubMed ID: 9315315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized, controlled chemoprevention trials in populations at very high risk for prostate cancer: Elevated prostate-specific antigen and high-grade prostatic intraepithelial neoplasia.
    Clark LC; Marshall JR
    Urology; 2001 Apr; 57(4 Suppl 1):185-7. PubMed ID: 11295623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of cancer mortality and incidence by selenium supplementation.
    Combs GF; Clark LC; Turnbull BW
    Med Klin (Munich); 1997 Sep; 92 Suppl 3():42-5. PubMed ID: 9342915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selenium supplementation, baseline plasma selenium status and incidence of prostate cancer: an analysis of the complete treatment period of the Nutritional Prevention of Cancer Trial.
    Duffield-Lillico AJ; Dalkin BL; Reid ME; Turnbull BW; Slate EH; Jacobs ET; Marshall JR; Clark LC;
    BJU Int; 2003 May; 91(7):608-12. PubMed ID: 12699469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral selenium supplementation has no effect on prostate-specific antigen velocity in men undergoing active surveillance for localized prostate cancer.
    Stratton MS; Algotar AM; Ranger-Moore J; Stratton SP; Slate EH; Hsu CH; Thompson PA; Clark LC; Ahmann FR
    Cancer Prev Res (Phila); 2010 Aug; 3(8):1035-43. PubMed ID: 20647337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase 3 clinical trial investigating the effect of selenium supplementation in men at high-risk for prostate cancer.
    Algotar AM; Stratton MS; Ahmann FR; Ranger-Moore J; Nagle RB; Thompson PA; Slate E; Hsu CH; Dalkin BL; Sindhwani P; Holmes MA; Tuckey JA; Graham DL; Parnes HL; Clark LC; Stratton SP
    Prostate; 2013 Feb; 73(3):328-35. PubMed ID: 22887343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Baseline characteristics and the effect of selenium supplementation on cancer incidence in a randomized clinical trial: a summary report of the Nutritional Prevention of Cancer Trial.
    Duffield-Lillico AJ; Reid ME; Turnbull BW; Combs GF; Slate EH; Fischbach LA; Marshall JR; Clark LC
    Cancer Epidemiol Biomarkers Prev; 2002 Jul; 11(7):630-9. PubMed ID: 12101110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opportunities and challenges in incorporating ancillary studies into a cancer prevention randomized clinical trial.
    Goodman PJ; Tangen CM; Darke AK; Arnold KB; Hartline J; Yee M; Anderson K; Caban-Holt A; Christen WG; Cassano PA; Lance P; Klein EA; Crowley JJ; Minasian LM; Meyskens FL
    Trials; 2016 Aug; 17():400. PubMed ID: 27519183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized double-blind placebo controlled phase I-II study on clinical and molecular effects of dietary supplements in men with precancerous prostatic lesions. Chemoprevention or "chemopromotion"?
    Gontero P; Marra G; Soria F; Oderda M; Zitella A; Baratta F; Chiorino G; Gregnanin I; Daniele L; Cattel L; Frea B; Brusa P
    Prostate; 2015 Aug; 75(11):1177-86. PubMed ID: 25893930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized, 12-year primary-prevention trial of beta carotene supplementation for nonmelanoma skin cancer in the physician's health study.
    Frieling UM; Schaumberg DA; Kupper TS; Muntwyler J; Hennekens CH
    Arch Dermatol; 2000 Feb; 136(2):179-84. PubMed ID: 10677093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT).
    Lippman SM; Klein EA; Goodman PJ; Lucia MS; Thompson IM; Ford LG; Parnes HL; Minasian LM; Gaziano JM; Hartline JA; Parsons JK; Bearden JD; Crawford ED; Goodman GE; Claudio J; Winquist E; Cook ED; Karp DD; Walther P; Lieber MM; Kristal AR; Darke AK; Arnold KB; Ganz PA; Santella RM; Albanes D; Taylor PR; Probstfield JL; Jagpal TJ; Crowley JJ; Meyskens FL; Baker LH; Coltman CA
    JAMA; 2009 Jan; 301(1):39-51. PubMed ID: 19066370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of antioxidant vitamins and selenium supplement in prostate cancer prevention: a meta-analysis of randomized controlled trials.
    Jiang L; Yang KH; Tian JH; Guan QL; Yao N; Cao N; Mi DH; Wu J; Ma B; Yang SH
    Nutr Cancer; 2010; 62(6):719-27. PubMed ID: 20661819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT).
    Klein EA; Thompson IM; Tangen CM; Crowley JJ; Lucia MS; Goodman PJ; Minasian LM; Ford LG; Parnes HL; Gaziano JM; Karp DD; Lieber MM; Walther PJ; Klotz L; Parsons JK; Chin JL; Darke AK; Lippman SM; Goodman GE; Meyskens FL; Baker LH
    JAMA; 2011 Oct; 306(14):1549-56. PubMed ID: 21990298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selenium and inhibition of disease progression in men diagnosed with prostate carcinoma: study design and baseline characteristics of the 'Watchful Waiting' Study.
    Stratton MS; Reid ME; Schwartzberg G; Minter FE; Monroe BK; Alberts DS; Marshall JR; Ahmann FR
    Anticancer Drugs; 2003 Sep; 14(8):595-600. PubMed ID: 14501381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Daily sunscreen application and betacarotene supplementation in prevention of basal-cell and squamous-cell carcinomas of the skin: a randomised controlled trial.
    Green A; Williams G; Neale R; Hart V; Leslie D; Parsons P; Marks GC; Gaffney P; Battistutta D; Frost C; Lang C; Russell A
    Lancet; 1999 Aug; 354(9180):723-9. PubMed ID: 10475183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Moving a randomized clinical trial into an observational cohort.
    Goodman PJ; Hartline JA; Tangen CM; Crowley JJ; Minasian LM; Klein EA; Cook ED; Darke AK; Arnold KB; Anderson K; Yee M; Meyskens FL; Baker LH
    Clin Trials; 2013 Feb; 10(1):131-42. PubMed ID: 23064404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selenium and prevention of prostate cancer in high-risk men: the Negative Biopsy Study.
    Stratton MS; Reid ME; Schwartzberg G; Minter FE; Monroe BK; Alberts DS; Marshall JR; Ahmann FR
    Anticancer Drugs; 2003 Sep; 14(8):589-94. PubMed ID: 14501380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.